Human papillomavirus vaccine uptake among 9-17 year old males in the United States: The National Health Interview survey, 2010

Tabassum H. Laz, Mahbubur Rahman, Abbey Berenson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

In 2009, a quadrivalent HPV vaccine was approved and 'permissively' recommended for US males aged 9 to 26 y to protect against genital warts. The purpose of this study was to examine parental awareness and HPV vaccine uptake among 9.17 y old males during the first year following this recommendation. Data from the 2010 National Health Interview Survey (NHIS) were obtained to assess vaccination status (n = 2973) of this age group. Univariate logistic regression analysis was performed to examine correlates of parental awareness and uptake of the HPV vaccine. Overall, 55% of parents with sons were aware of the HPV vaccine. The likelihood of parental awareness was lower among minorities and adolescents with low family incomes, and higher among adolescents with insurance, higher parental education, and those who had a well-child check up and dental examination in the past year than their counterparts. Only 2.0% and 0.5% of 9.17 y old males initiated (≥ 1 dose) and completed (≥ 3 doses) the vaccine series, respectively. Adolescents with a Hispanic origin (odds ratio (OR ) 2.03, 95% confidence interval (CI) 1.09.3.78), low family income (OR 2.89, 95% CI 1.48.5.57), and history of influenza vaccination in the past year (OR 1.89, 95% CI 1.11.3.22) were more likely than their counterparts to initiate the HPV vaccine. On the other hand, adolescents with private insurance (OR 0.44, 95% CI 0.20.0.94) and those who had college educated parents (OR 0.45, 95% CI 0.22.0.89) were less likely to initiate the vaccine. This study showed that very few adolescent males received any doses of HPV vaccine during the first year following its recommendation for this gender. Thus, interventional programs are needed to improve vaccine uptake among adolescent males.

Original languageEnglish (US)
Pages (from-to)874-878
Number of pages5
JournalHuman Vaccines and Immunotherapeutics
Volume9
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Papillomavirus Vaccines
Health Surveys
Interviews
Odds Ratio
Confidence Intervals
Vaccines
Insurance
Vaccination
Parents
Condylomata Acuminata
Nuclear Family
Hispanic Americans
Human Influenza
Tooth
Age Groups
Logistic Models
Regression Analysis
Education

Keywords

  • Adolescent males
  • HPV Vaccine
  • Human papillomavirus
  • National Health Interview Survey
  • Uptake

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Human papillomavirus vaccine uptake among 9-17 year old males in the United States : The National Health Interview survey, 2010. / Laz, Tabassum H.; Rahman, Mahbubur; Berenson, Abbey.

In: Human Vaccines and Immunotherapeutics, Vol. 9, No. 4, 04.2013, p. 874-878.

Research output: Contribution to journalArticle

@article{d6db6ca6d9d14e0f9eaa855c920d222f,
title = "Human papillomavirus vaccine uptake among 9-17 year old males in the United States: The National Health Interview survey, 2010",
abstract = "In 2009, a quadrivalent HPV vaccine was approved and 'permissively' recommended for US males aged 9 to 26 y to protect against genital warts. The purpose of this study was to examine parental awareness and HPV vaccine uptake among 9.17 y old males during the first year following this recommendation. Data from the 2010 National Health Interview Survey (NHIS) were obtained to assess vaccination status (n = 2973) of this age group. Univariate logistic regression analysis was performed to examine correlates of parental awareness and uptake of the HPV vaccine. Overall, 55{\%} of parents with sons were aware of the HPV vaccine. The likelihood of parental awareness was lower among minorities and adolescents with low family incomes, and higher among adolescents with insurance, higher parental education, and those who had a well-child check up and dental examination in the past year than their counterparts. Only 2.0{\%} and 0.5{\%} of 9.17 y old males initiated (≥ 1 dose) and completed (≥ 3 doses) the vaccine series, respectively. Adolescents with a Hispanic origin (odds ratio (OR ) 2.03, 95{\%} confidence interval (CI) 1.09.3.78), low family income (OR 2.89, 95{\%} CI 1.48.5.57), and history of influenza vaccination in the past year (OR 1.89, 95{\%} CI 1.11.3.22) were more likely than their counterparts to initiate the HPV vaccine. On the other hand, adolescents with private insurance (OR 0.44, 95{\%} CI 0.20.0.94) and those who had college educated parents (OR 0.45, 95{\%} CI 0.22.0.89) were less likely to initiate the vaccine. This study showed that very few adolescent males received any doses of HPV vaccine during the first year following its recommendation for this gender. Thus, interventional programs are needed to improve vaccine uptake among adolescent males.",
keywords = "Adolescent males, HPV Vaccine, Human papillomavirus, National Health Interview Survey, Uptake",
author = "Laz, {Tabassum H.} and Mahbubur Rahman and Abbey Berenson",
year = "2013",
month = "4",
doi = "10.4161/hv.23190",
language = "English (US)",
volume = "9",
pages = "874--878",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Human papillomavirus vaccine uptake among 9-17 year old males in the United States

T2 - The National Health Interview survey, 2010

AU - Laz, Tabassum H.

AU - Rahman, Mahbubur

AU - Berenson, Abbey

PY - 2013/4

Y1 - 2013/4

N2 - In 2009, a quadrivalent HPV vaccine was approved and 'permissively' recommended for US males aged 9 to 26 y to protect against genital warts. The purpose of this study was to examine parental awareness and HPV vaccine uptake among 9.17 y old males during the first year following this recommendation. Data from the 2010 National Health Interview Survey (NHIS) were obtained to assess vaccination status (n = 2973) of this age group. Univariate logistic regression analysis was performed to examine correlates of parental awareness and uptake of the HPV vaccine. Overall, 55% of parents with sons were aware of the HPV vaccine. The likelihood of parental awareness was lower among minorities and adolescents with low family incomes, and higher among adolescents with insurance, higher parental education, and those who had a well-child check up and dental examination in the past year than their counterparts. Only 2.0% and 0.5% of 9.17 y old males initiated (≥ 1 dose) and completed (≥ 3 doses) the vaccine series, respectively. Adolescents with a Hispanic origin (odds ratio (OR ) 2.03, 95% confidence interval (CI) 1.09.3.78), low family income (OR 2.89, 95% CI 1.48.5.57), and history of influenza vaccination in the past year (OR 1.89, 95% CI 1.11.3.22) were more likely than their counterparts to initiate the HPV vaccine. On the other hand, adolescents with private insurance (OR 0.44, 95% CI 0.20.0.94) and those who had college educated parents (OR 0.45, 95% CI 0.22.0.89) were less likely to initiate the vaccine. This study showed that very few adolescent males received any doses of HPV vaccine during the first year following its recommendation for this gender. Thus, interventional programs are needed to improve vaccine uptake among adolescent males.

AB - In 2009, a quadrivalent HPV vaccine was approved and 'permissively' recommended for US males aged 9 to 26 y to protect against genital warts. The purpose of this study was to examine parental awareness and HPV vaccine uptake among 9.17 y old males during the first year following this recommendation. Data from the 2010 National Health Interview Survey (NHIS) were obtained to assess vaccination status (n = 2973) of this age group. Univariate logistic regression analysis was performed to examine correlates of parental awareness and uptake of the HPV vaccine. Overall, 55% of parents with sons were aware of the HPV vaccine. The likelihood of parental awareness was lower among minorities and adolescents with low family incomes, and higher among adolescents with insurance, higher parental education, and those who had a well-child check up and dental examination in the past year than their counterparts. Only 2.0% and 0.5% of 9.17 y old males initiated (≥ 1 dose) and completed (≥ 3 doses) the vaccine series, respectively. Adolescents with a Hispanic origin (odds ratio (OR ) 2.03, 95% confidence interval (CI) 1.09.3.78), low family income (OR 2.89, 95% CI 1.48.5.57), and history of influenza vaccination in the past year (OR 1.89, 95% CI 1.11.3.22) were more likely than their counterparts to initiate the HPV vaccine. On the other hand, adolescents with private insurance (OR 0.44, 95% CI 0.20.0.94) and those who had college educated parents (OR 0.45, 95% CI 0.22.0.89) were less likely to initiate the vaccine. This study showed that very few adolescent males received any doses of HPV vaccine during the first year following its recommendation for this gender. Thus, interventional programs are needed to improve vaccine uptake among adolescent males.

KW - Adolescent males

KW - HPV Vaccine

KW - Human papillomavirus

KW - National Health Interview Survey

KW - Uptake

UR - http://www.scopus.com/inward/record.url?scp=84877122189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877122189&partnerID=8YFLogxK

U2 - 10.4161/hv.23190

DO - 10.4161/hv.23190

M3 - Article

C2 - 23295743

AN - SCOPUS:84877122189

VL - 9

SP - 874

EP - 878

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 4

ER -